Optimization of Antibiotic Treatment in Patients With a Reported Penicillin Allergy Using a Digital Clinical Decision Support Tool.
Sponsor: Althaia Xarxa Assistencial Universitària de Manresa
Trial Details
| Condition | Reported Penicillin Allergy in Hospitalized Patients With Infections |
| Status | Completed |
| Participants | 182 |
| Est. Completion | 3 Apr 2026 |
| Last Updated | 29 May 2026 |
Primary Outcome
Proportion of patients receiving empirical beta-lactam antibiotics
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Age ≥ 16 years * Hospitalized patients * Diagnosis of infection requiring systemic antibiotic therapy * Documented penicillin and/or cephalosporin allergy in the electronic medical record or self-reported allergy during current admission * For the retrospective cohort: patients previously admitted to hospital or emergency department (≥16 hours) with a recorded penicillin allergy label * Ability to understand study information and provision of written informed consent (prospective cohort only) Exclusion Criteria: * Patients with a reported penicillin allergy who do not require systemic antibiotic treatment * Patients admitted to intensive care or intermediate care units * Patients receiving outpatient hospital care or dialysis units * Patients in end-of-life care or receiving palliative care * Patients receiving antibiotics for surgical prophylaxis only
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service